FDA, Abbott Nutrition Agree To Restart Infant Formula Production To Address Nationwide Shortage

The United States Food and Drug Administration (FDA) and Abbott Nutrition have agreed to restart manufacturing operations at the Sturgis facility to address the nationwide shortage. The situation comes as the specific facility was shut down after the discovery of bacteria.